Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

NPCENPCE
8 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in NEUROPACE INC

Yes. JPMorgan Chase holds 173,311 shares of NPCE (Neuropace), worth $2.9M, as of its Q2 2026 13F filing. It increased the position by 32,170 shares (+22.8%) from Q1 2026. JPMorgan Chase has held NPCE in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$2.9M

Current Shares

173,311

Total Value Change

+$2.8M

Total Shares Change

+161,314

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
173,311
+22.8%
$2.9M0.0%$15.89
32
2026-Q1
Increased
141,141
+7.8%
$1.8M0.0%$13.83
28
2025-Q4
Increased
130,926
+1175.0%
$2M0.0%$15.47
42
2025-Q3
Decreased
10,269
-11.8%
$105,8730.0%$10.24
0
2025-Q2
Decreased
11,643
-73.4%
$129,7030.0%$10.71
0
2025-Q1
Decreased
43,792
-32.5%
$538,2030.0%$11.85
0
2024-Q4
Increased
64,826
+440.4%
$725,4030.0%$11.19
40
2024-Q3
First report
11,997
-
$83,6190.0%$6.97
0

Other major holders of NPCE: Polar Capital Holdings Plc, MORGAN STANLEY, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used